Retrospective naturalistic study compares response to high-frequency rTMS in unipolar versus bipolar depression, suggesting differences in effectiveness.
Objective This retrospective naturalistic study compared response patterns and tolerability of high-frequency left-DLPFC repetitive transcranial magnetic stimulation (rTMS) in patients with major depressive disorder (MDD) and bipolar depressive disorder (BD) under real-world clinical conditions.Materials and Methods A total of 161 patients (95 MDD, 66 BD) who completed 20 sessions of 10 Hz rTMS between 2019 and 2023 were evaluated. Diagnoses were established using the SCID-5. Symptom severity was assessed with the Hamilton Depression Rating Scale (HAM-D). Response was defined as ≥50% HAM-D reduction, remission as post-treatment HAM-D ≤ 7. Multivariate logistic regression identified independent predictors of response.Results The MDD group demonstrated a significantly higher response rate than the BD group (48.4% vs. 28.8%; p = 0.013), while remission rates were comparable (21.1% vs. 21.2%; p = 1.000). Female patients exhibited higher response rates in both groups, reaching significance in MDD (58.8% vs. 36.4%, p = 0.029). Multivariate analysis confirmed diagnosis (OR = 2.25, p = 0.025), female sex (OR = 2.35, p = 0.014), and lower baseline HAM-D scores (OR = 0.85, p = 0.018) as independent predictors of response. rTMS was well tolerated, with mild transient side effects in 36.6% of participants and only one hypomanic activation.Conclusion In this naturalistic sample, MDD showed a higher response than BD, while remission rates were comparable. Given the retrospective, completer-based design and asymmetric sampling, these findings are exploratory and should inform future controlled studies rather than current clinical practice.
No takes yet. Share an insight, caveat, or question.
Sancaktar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: